Fanny Cavalié
Chief Operating Officer chez FOGHORN THERAPEUTICS INC.
Fortune : 509 906 $ au 31/03/2024
Profil
Fanny Cavalié is currently the Chief Strategy & Business Operations Officer at Foghorn Therapeutics, Inc. She previously worked at Biogen, Inc. as the Head-Multiple Sclerosis Portfolio Strategy from 2014 to 2018.
Prior to that, she was an Associate Partner at McKinsey & Co., Inc. (United Kingdom) from 2003 to 2014.
Ms. Cavalié holds an MBA from École des Hautes Études Commerciales de Paris, which she obtained in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/03/2024 | 75 992 ( 0,18% ) | 509 906 $ | 31/03/2024 |
Postes actifs de Fanny Cavalié
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Operating Officer | - |
Anciens postes connus de Fanny Cavalié
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2018 |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The private company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Corporate Officer/Principal | 01/05/2014 |
Formation de Fanny Cavalié
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The private company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Finance |
